Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01772797 |
| Title | Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung Cancer |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | ITA | ESP | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Colorado Dept. of Anschutz Cancer (3) | Aurora | Colorado | 80045 | United States | Details | |
| Massachusetts General Hospital Mass General | Boston | Massachusetts | 02114 | United States | Details | |
| Fox Chase Cancer Center Fox Chase Cancer (2) | Philadelphia | Pennsylvania | 19111-2497 | United States | Details | |
| University of Utah / Huntsman Cancer Institute Huntsman | Salt Lake City | Utah | 84103 | United States | Details | |
| Novartis Investigative Site | Melbourne | Victoria | 3000 | Australia | Details | |
| Novartis Investigative Site | Milano | MI | 20141 | Italy | Details | |
| Novartis Investigative Site | Singapore | 169610 | Singapore | Details | ||
| Novartis Investigative Site | Barcelona | Catalunya | 08035 | Spain | Details |